Study title: A multicentre, randomised, double-blind, parallel, placebo controlled study of two dosing regimens of valaciclovir compared to placebo for the prevention/blockage of the progression of the cold sore lesion beyond the papular stage.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Virus Diseases | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: VALACICLOVIR | |||||
ATC code: J05AB11 | |||||
Document link: Valaciclovir-HS230028-ICHE3.pdf | |||||
Document date: 2011-09-23 | |||||
Study number: HS230028 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |